Immune checkpoint inhibitors

Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review
Peter Galle, Richard S Finn, Catherine Ruth Mitchell, Kerigo Ndirangu, Zahra Ramji, Gabrielle Sophie Redhead, David J Pinato

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008266; DOI: 10.1136/jitc-2023-008266
Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy
Yao Wang, Tingting Zhu, Qi Shi, Guanghui Zhu, Siwei Zhu, Fenggang Hou

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008026; DOI: 10.1136/jitc-2023-008026
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Claire Quaghebeur, Bjørnar Gilje, Beate Boge, Andrea Gombos, Ragnhild Sørum Falk, Randi R. Mathiesen, Lars Julsrud, Øystein Garred, Hege G. Russnes, Ragnhild Reehorst Lereim, Sudhir Kumar Chauhan, Ole Christian Lingjærde, Claire Dunn, Bjørn Naume, Jon Amund Kyte

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e007990; DOI: 10.1136/jitc-2023-007990
Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
Bingting Yu, Maikel Peppelenbosch, Gwenny Fuhler

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008422; DOI: 10.1136/jitc-2023-008422
Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer
Chuanjia Gu, Xue Wang, Kaiyu Wang, Fangfang Xie, Luonan Chen, Hongbin Ji, Jiayuan Sun

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008386; DOI: 10.1136/jitc-2023-008386
Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma
Feng Zhang, Wenfeng Liu, Fansheng Meng, Qiuyu Jiang, Wenqing Tang, Zhiyong Liu, Xiahui Lin, Ruyi Xue, Si Zhang, Ling Dong

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008094; DOI: 10.1136/jitc-2023-008094
LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy
Lingjuan Sun, Zhibo Ma, Xiangli Zhao, Xiaosheng Tan, Yuhao Tu, Jingzeng Wang, Li Chen, Zhishui Chen, Gang Chen, Peixiang Lan

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008367; DOI: 10.1136/jitc-2023-008367
Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy
Zhiqiang Mo, Ling Lv, Qicong Mai, Qiao Li, Jian He, Tao Zhang, Jingwu Xu, Jiayan Fang, Ning Shi, Qing Gou, Xiaoming Chen, Jing Zhang, Wenhang Zhuang, Haosheng Jin

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008191; DOI: 10.1136/jitc-2023-008191
Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial
Ning Jiang, Jingyuan Zhang, Zhen Guo, Yinan Wu, Lijun Zhao, Cheng Kong, Xue Song, Lingling Gu, Yang Zhao, Si Li, Xia He, Binhui Ren, Xiangzhi Zhu, Ming Jiang

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008229; DOI: 10.1136/jitc-2023-008229
Effects of antineoplastic and immunomodulating agents on postvaccination SARS-CoV-2 breakthrough infections, antibody response, and serological cytokine profile
Jacob New, Jason Cham, Lana Smith, Leah Puglisi, Tridu Huynh, Sunil Kurian, Samantha Bagsic, Russel Fielding, Lee Hong, Priya Reddy, Ki Suk Eum, Allison Martin, Bethany Barrick, Christopher Marsh, Michael Quigley, Laura J Nicholson, Amitabh C Pandey

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008233; DOI: 10.1136/jitc-2023-008233

Main menu

Immune checkpoint inhibitors

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immune checkpoint inhibitors

Pages